Cargando…

The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders

NANOG, a key regulator of pluripotency and self-renewal in embryonic and adult stem cells, is frequently overexpressed in multiple cancers, including oral squamous cell carcinoma (OSCC). It has been frequently associated with poor outcomes in epithelial cancers, and recently implicated in laryngeal...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vicente, Juan C., Rodríguez-Santamarta, Tania, Rodrigo, Juan P., Allonca, Eva, Vallina, Aitana, Singhania, Anusha, Donate-Pérez del Molino, Paula, García-Pedrero, Juana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780631/ https://www.ncbi.nlm.nih.gov/pubmed/31484317 http://dx.doi.org/10.3390/jcm8091376

Ejemplares similares

SOX2 Expression Is an Independent Predictor of Oral Cancer Progression
por: de Vicente, Juan C., et al.
Publicado: (2019)

Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders
por: de Villalaín, Lucas, et al.
Publicado: (2023)

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions
por: Rodrigo, Juan P., et al.
Publicado: (2017)

Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020)

Frequent Alteration of Annexin A9 and A10 in HPV-Negative Head and Neck Squamous Cell Carcinomas: Correlation with the Histopathological Differentiation Grade
por: Salom, Cecilia, et al.
Publicado: (2019)

The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell Carcinoma
por: Sanchez-Canteli, Mario, et al.
Publicado: (2020)

Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression
por: Suárez-Sánchez, Faustino J., et al.
Publicado: (2020)

Tumor-Infiltrating CD20(+) B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment
por: Suárez-Sánchez, Faustino Julián, et al.
Publicado: (2021)

Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer
por: Lequerica-Fernández, Paloma, et al.
Publicado: (2023)

Prognostic Relevance of CD4(+), CD8(+) and FOXP3(+) TILs in Oral Squamous Cell Carcinoma and Correlations with PD-L1 and Cancer Stem Cell Markers
por: Lequerica-Fernández, Paloma, et al.
Publicado: (2021)

Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment
por: Ruiz-Ranz, Marta, et al.
Publicado: (2022)

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2020)

Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas
por: Rodrigo, Juan P., et al.
Publicado: (2015)

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models()
por: Martinez-Cruzado, Lucia, et al.
Publicado: (2017)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions
por: Granda-Díaz, Rocío, et al.
Publicado: (2019)

Relevance of level IIb neck dissection in oral squamous cell carcinoma
por: de Vicente, Juan-Carlos, et al.
Publicado: (2015)

Esrrb Is a Direct Nanog Target Gene that Can Substitute for Nanog Function in Pluripotent Cells
por: Festuccia, Nicola, et al.
Publicado: (2012)

Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma
por: Grubelnik, Gašper, et al.
Publicado: (2020)

Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells
por: Eberle, Irina, et al.
Publicado: (2010)

On the Origin and Evolutionary History of NANOG
por: Scerbo, Pierluigi, et al.
Publicado: (2014)

Nanog Heterogeneity: Tilting at Windmills?
por: Smith, Austin
Publicado: (2013)

SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications
por: Menendez, Sofia T., et al.
Publicado: (2020)

Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case–Control Study
por: López-Jornet, Pia, et al.
Publicado: (2023)

A NANOG‐pERK reciprocal regulatory circuit regulates Nanog autoregulation and ERK signaling dynamics
por: Kale, Hanuman T, et al.
Publicado: (2022)

Distinct Expression and Clinical Significance of Zinc Finger AN-1-Type Containing 4 in Oral Squamous Cell Carcinomas
por: Suarez-Canto, Julián, et al.
Publicado: (2018)

Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
por: Hermida-Prado, Francisco, et al.
Publicado: (2018)

Nanog Is the Gateway to the Pluripotent Ground State
por: Silva, Jose, et al.
Publicado: (2009)

Genome editing demonstrates that the −5 kb Nanog enhancer regulates Nanog expression by modulating RNAPII initiation and/or recruitment
por: Agrawal, Puja, et al.
Publicado: (2020)

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
por: García-Carracedo, Darío, et al.
Publicado: (2016)

Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium
por: Al-Kaabi, Methaq, et al.
Publicado: (2022)

Potential Histopathological and Immune Biomarkers in Malignant and Non-Malignant Oral Lesions
por: de Souza, Vinícius Gonçalves, et al.
Publicado: (2022)

Characterization of the Nanog 5′-flanking Region in Bovine
por: Choi, Don-Ho, et al.
Publicado: (2016)

Characterization of the porcine Nanog 5′-flanking region
por: Memon, Azra, et al.
Publicado: (2018)

ZMYM2 inhibits NANOG-mediated reprogramming
por: Lawrence, Moyra, et al.
Publicado: (2019)

Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells
por: Ye, Feng, et al.
Publicado: (2008)

NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma
por: WATANABE, MASAHIRO, et al.
Publicado: (2014)

SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis
por: Swain, Niharika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k4dpcufbs3c9s30n402lfl4n89